Promising Phase II Results for Hard-to-Treat Liver Disease
The NASH trial achieved the primary endpoint of proton density fat fraction and the secondary endpoint of cT1.
Source: biospace.com
Christopherp Recknor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Christopherp Recknor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Christopherp Recknor Today - Breaking & Trending Today
CytoDyn Inc announces positive results from part two of Phase 2 Nonalcoholic steatohepatitis clinical trial
Part one compared a 700 mg weekly dose and placebo in a double-blind randomized manner and Part two evaluated a 350 mg weekly dose as an...
Source: proactiveinvestors.com
.jpg)
NA Proactive news snapshot: Context Therapeutics Inc., Plurilock Security Inc., Kontrol Technologies Corp., Zoglo's Incredible Food Corp., , Fobi AI Inc, Vicinity Motor Corp, Ultra Resources Inc, Mindset Pharma Inc, Ayurcann Holdings Corp, Altaley Mining
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Source: proactiveinvestors.com
Leronlimab 14-Week, NASH Clinical Trial Met Primary Endpoint (PDFF) and Secondary Endpoint (cT1) for
Primary endpoint (PDFF) was achieved in both Intention to Treat and Per Protocol PopulationsVANCOUVER, Wash.--(BUSINESS WIRE)--CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications,...
Source: pharmiweb.com
NA Proactive news snapshot: Fobi AI Inc, Vicinity Motor Corp, Ultra Resources Inc, Mindset Pharma Inc, Ayurcann Holdings Corp, Altaley Mining Corporation, Magna Mining Inc, Bragg Gaming Group Inc, American Manganese Inc, Clean Air Metals Inc, KetamineOne
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Source: proactiveinvestors.com